Bovie Medical Reports Positive Results on J-Plasma

J-Plasma Bovie Medical We've had a busy week at Bovie with a press release on our J-Plasma progress out on the 10th. Followed by internal business meetings in New York on the 11th and then a Board Meeting and Shareholder meeting on the 12th. I thought the Shareholder meeting went well with good questions and suggestions from those in attendance.

If you missed the press release, then here it is...

"Melville, New York, July 10, 2012 - Bovie Medical Corporation (the “Company”) (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products, today announced that J-Plasma™ is performing well in both laparoscopic and open surgeries. In multiple patient procedures there was a decrease in smoke, less charring and overall excellent tissue response when compared to current electrosurgery devices. Jeff Rencher, Vice President of Sales and Marketing of Surgical Products stated, “The positive results achieved by J-Plasma™ met all expectations as we prepare to embark on an aggressive marketing program for the product.”

He added, “We will continue to introduce J-Plasma™ in a limited format over the next two weeks; however, with the early success of the product in human cases and the continued success and extensive use in live veterinarian cases, we will be moving into expanded markets during the current quarter. Gynecology and Plastic Surgery will continue to be the main focus for J-Plasma™. Additionally, we expect to be performing ENT and General Surgery procedures as the technology establishes itself as a viable alternative to traditional and competitive devices.”

In unrelated news, the Company reported that it’s previously announced anticipated developmental and manufacturing agreement with a large multi-national medical device company remains in the due-diligence and negotiation stage."